EpiBone key facts
as of Oct 2026- Developer of a bone reconstruction technology designed for skeletal reconstruction through three-dimensional design and living cells.
- EpiBone is valued at approximately $44.3M as of Oct 2026 (last reported valuation).
- It has raised $71.1M across 4 recorded rounds; the latest was Seed Round ($4.3M) in Sep 2025.
- Notable investors include Impact Assets, United States Department of War, Alexandria Venture Investments, Hub71, Johnson & Johnson Innovation - JLABS — 50 tracked in total.
- 1 investment vehicle was formed to buy EpiBone shares in the last 12 months, reporting $1.1M sold to 19 investors, per SEC Form D filings.
- EpiBone has filed 3 Form Ds with the SEC since 2020, most recently Dec 2022 ($18.5M sold to 51 investors).
- Status: Privately Held (backing).
EpiBone's last reported valuation, Jan 2020. Nothing priced has surfaced since.
- ·The complete investor list: 50 names
- ·Watch EpiBone: the Monday email on marks, rounds and moves
EpiBone funding rounds
4 roundsVehicles formed to buy EpiBone shares
secondary demand · SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy EpiBone shares, reporting $1.1M sold to 19 investors. Most recent filing Mar 2026.
Membership and data by Private Market View
Who backs EpiBone
50+EpiBone valuation
EpiBone's last reported valuation was $44.3 million in Jan 2020. No priced round, secondary trade or fund mark has surfaced since.
How much has EpiBone raised?
EpiBone has raised $71.1 million across 4 recorded rounds since 2020. The largest was a $750,000 later-stage round in Feb 2021; the most recent was a $4.3 million seed round in Sep 2025.
EpiBone has filed 3 Form Ds with the SEC since 2020, most recently in Dec 2022 ($18.5 million sold to 51 investors).
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy EpiBone shares, reporting $1.1 million sold to 19 investors, per SEC Form D filings (most recent Mar 2026).
EpiBone investors
50 investors are on record for EpiBone, including Impact Assets, United States Department of War, Alexandria Venture Investments and Hub71. By type, the record holds 10 venture capital firms and 1 angel investor. The seed round in Sep 2025 drew 131 investors.
Comparable companies
Comparable other healthcare technology systems names by valuation on PrivateMarketView: August Health ($65 million), BellaLift ($43 million) and Welltory ($29 million).
About EpiBone
Developer of a bone reconstruction technology designed for skeletal reconstruction through three-dimensional design and living cells. The company's technology utilizes a scan of the bone defect and the patient's own stem cells to construct and cultivate a defect-specific autologous-like bone graft, enabling clinicians to provide patients with a bone graft through a simplified surgical procedure, improved bone formation, regeneration, and short recovery times.
- Industry
- Other Healthcare Technology Systems
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2013
- Employees
- 21
- Website
- epibone.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.